{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:47:06Z","timestamp":1789469226092,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20-22mk0101184"],"award-info":[{"award-number":["JP20-22mk0101184"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17-21ak0101073"],"award-info":[{"award-number":["JP17-21ak0101073"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22-24ak0101185"],"award-info":[{"award-number":["JP22-24ak0101185"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24-26mk0121301"],"award-info":[{"award-number":["JP24-26mk0121301"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.dmpk.2026.101545","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:49:23Z","timestamp":1781884163000},"page":"101545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and validation of LC\u2013MS-based bioanalytical methods for oligonucleotide therapeutics: points to consider"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5452-8829","authenticated-orcid":false,"given":"Yuchen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoya","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6057-0596","authenticated-orcid":false,"given":"Masaaki","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-2931","authenticated-orcid":false,"given":"Yoshiharu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-3743","authenticated-orcid":false,"given":"Tomomi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Shimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Jinno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Murakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruri","family":"Kikura-Hanajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6669-8152","authenticated-orcid":false,"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2026.101545_bib2","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.dmpk.2026.101545_bib3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.xphs.2024.04.021","article-title":"A review on commercial oligonucleotide drug products","volume":"113","author":"Vinjamuri","year":"2024","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2026.101545_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmpk.2026.101545_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415474","article-title":"Bioanalysis of oligonucleotide by LC\u2013MS: effects of ion pairing regents and recent advances in ion-pairing-free analytical strategies","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dmpk.2026.101545_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4155\/bio-2023-0032","article-title":"Ligand-binding assays vs chromatographic platforms for oligonucleotide quantification","volume":"15","author":"White","year":"2023","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.4155\/bio.11.111","article-title":"Oligonucleotide bioanalysis: sensitivity versus specificity","volume":"3","author":"Wang","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5702\/massspec.S23-20","article-title":"Developmental strategies and method validation of LC\u2013MS-Based bioanalytical methods for oligonucleotide therapeutics","volume":"71","author":"Sun","year":"2023","journal-title":"J Mass Spectrom Soc Jpn"},{"key":"10.1016\/j.dmpk.2026.101545_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4155\/bio-2019-0031","article-title":"An oligonucleotide bioanalytical LC-SRM methodology entirely liberated from ion-pairing","volume":"11","author":"Macneill","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4155\/bio-2021-0216","article-title":"Novel hydrophilic-phase extraction, HILIC and high-resolution MS quantification of an RNA oligonucleotide in plasma","volume":"14","author":"Anand","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465378","article-title":"Current state of hydrophilic interaction liquid chromatography of oligonucleotides","volume":"1736","author":"Bartlett","year":"2024","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.dmpk.2026.101545_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.chroma.2010.12.051","article-title":"Separation of oligonucleotide phosphorothioate diastereoisomers by pellicular anion-exchange chromatography","volume":"1218","author":"Thayer","year":"2011","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.dmpk.2026.101545_bib13","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/acs.analchem.0c00114","volume":"92","author":"Goyon","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmpk.2026.101545_bib14","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1021\/jasms.4c00270","article-title":"Overcoming challenges in oligonucleotide therapeutics analysis: a novel nonion pair approach","volume":"35","author":"Hayashi","year":"2024","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.dmpk.2026.101545_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1021\/jasms.4c00081","article-title":"Analysis of self-assembled micelle inhibitory RNA (SAMiRNA) drug using ion-pairing reversed-phase liquid chromatography combined with mass spectrometry","volume":"35","author":"Hwang","year":"2024","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.dmpk.2026.101545_bib16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.4155\/bio-2020-0225","article-title":"Development of a bioanalytical method for an antisense therapeutic using high-resolution mass spectrometry","volume":"12","author":"Sun","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4155\/bio-2022-0126","article-title":"Development and multicenter validation of an LC\u2013MS-based bioanalytical method for antisense therapeutics","volume":"14","author":"Sun","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/ac960916h","article-title":"Analysis of oligonucleotides by HPLC\u2212electrospray ionization mass spectrometry","volume":"69","author":"Apffel","year":"1997","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmpk.2026.101545_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.462860","article-title":"Effect of ion-pairing reagent hydrophobicity on liquid chromatography and mass spectrometry analysis of oligonucleotides","volume":"1666","author":"Donegan","year":"2022","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.dmpk.2026.101545_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/mas.21641","article-title":"Bioanalysis and biotransformation of oligonucleotide therapeutics by liquid chromatography-mass spectrometry","volume":"40","author":"Sutton","year":"2021","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.dmpk.2026.101545_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/10408347.2018.1517034","article-title":"Analysis of antisense oligonucleotides and their metabolites with the use of ion pair reversed-phase liquid chromatography coupled with mass spectrometry","volume":"49","author":"Kaczmarkiewicz","year":"2019","journal-title":"Crit Rev Anal Chem"},{"key":"10.1016\/j.dmpk.2026.101545_bib22","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/jasms.3c00264","article-title":"Mobile phase aging and its impact on electrospray ionization of oligonucleotides","volume":"34","author":"Guimaraes","year":"2023","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.dmpk.2026.101545_bib23","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2021-0084","article-title":"The critical role of mobile phase pH in the performance of oligonucleotide ion-pair liquid chromatography-mass spectrometry methods","volume":"7","author":"Guimaraes","year":"2021","journal-title":"Future Sci OA"},{"key":"10.1016\/j.dmpk.2026.101545_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4155\/bio-2024-0007","article-title":"Observations from a decade of oligonucleotide bioanalysis by LC\u2013MS","volume":"16","author":"Ewles","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114439","article-title":"Impact of nonspecific adsorption to metal surfaces in ion pair-RP LC\u2013MS impurity analysis of oligonucleotides","volume":"208","author":"Guimaraes","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dmpk.2026.101545_bib26","author":"US"},{"key":"10.1016\/j.dmpk.2026.101545_bib28","article-title":"Clinical pharmacology considerations for the development of oligonucleotide therapeutics","author":"US","year":"2024","journal-title":"Guidance Industry"},{"key":"10.1016\/j.dmpk.2026.101545_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/nat.2023.0011","article-title":"OSWG recommended approaches to the nonclinical pharmacokinetic (ADME) characterization of therapeutic oligonucleotides","volume":"33","author":"Berman","year":"2023","journal-title":"Nucleic Acid Therapeut"},{"key":"10.1016\/j.dmpk.2026.101545_bib35","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/molecules28041618","article-title":"A novel hybridization LC\u2013MS\/MS methodology for quantification of siRNA in plasma, CSF and tissue samples","volume":"28","author":"Yuan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.dmpk.2026.101545_bib36","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.4155\/bio-2017-0145","article-title":"Quantitative analysis of imetelstat in plasma with LC\u2013MS\/MS using solid-phase or hybridization extraction","volume":"9","author":"Dillen","year":"2017","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4155\/bio.13.319","article-title":"Quantification of oligonucleotides by LC\u2013MS\/MS: the challenges of quantifying a phosphorothioate oligonucleotide and multiple metabolites","volume":"6","author":"Ewles","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4155\/bio-2021-0134","article-title":"High-sensitivity workflow for LC\u2013MS-based analysis of GalNAc-conjugated oligonucleotides: a case study","volume":"13","author":"Ledvina","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib39","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.4155\/bio-2019-0134","article-title":"LC-TOF-MS methods to quantify siRNAs and major metabolite in plasma, urine and tissues","volume":"11","author":"Ramanathan","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib40","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1021\/acs.analchem.5c01587","article-title":"Differential protein precipitation-based GalNAc-siRNA sample preparation with LC\/MS method development workflow in plasma","volume":"97","author":"Kim","year":"2025","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmpk.2026.101545_bib41","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.3390\/ijms23179546","article-title":"Oligonucleotides isolation and separation-A review on adsorbent selection","volume":"23","author":"Studzi\u0144ska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dmpk.2026.101545_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpba.2012.06.022","article-title":"Development and validation of LC\u2013MS\/MS method for the detection and quantification of CpG oligonucleotides 107 (CpG ODN107) and its metabolites in mice plasma","volume":"70","author":"Cen","year":"2012","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dmpk.2026.101545_bib43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1208\/s12248-012-9394-x","article-title":"A one-step solid phase extraction method for bioanalysis of a phosphorothioate oligonucleotide and its 3\u2032 n-1 metabolite from rat plasma by uHPLC\u2013MS\/MS","volume":"14","author":"Chen","year":"2012","journal-title":"AAPS J"},{"key":"10.1016\/j.dmpk.2026.101545_bib44","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.omtn.2019.07.006","article-title":"Metabolite profiling of the antisense oligonucleotide Eluforsen using liquid chromatography-mass spectrometry","volume":"17","author":"Kim","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.dmpk.2026.101545_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.26","article-title":"Disposition and pharmacology of a GalNAc3-conjugated ASO targeting Human lipoprotein (a) in mice","volume":"5","author":"Yu","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.dmpk.2026.101545_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10928-014-9398-5","article-title":"Pharmacokinetic-pharmacodynamic modeling for reduction of hepatic apolipoprotein B mRNA and plasma total cholesterol after administration of antisense oligonucleotide in mice","volume":"42","author":"Shimizu","year":"2015","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.dmpk.2026.101545_bib47","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4155\/bio-2019-0117","article-title":"LC\u2013MS quantification of oligonucleotides in biological matrices with SPE or hybridization extraction","volume":"11","author":"Sips","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib48","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1021\/acs.analchem.0c01382","article-title":"Hybridization liquid chromatography-tandem mass spectrometry: an alternative bioanalytical method for antisense oligonucleotide quantitation in plasma and tissue samples","volume":"92","author":"Li","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmpk.2026.101545_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4155\/bio-2022-0015","article-title":"Validation and application of hybridization liquid chromatography-tandem mass spectrometry methods for quantitative bioanalysis of antisense oligonucleotides","volume":"14","author":"Li","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib50","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4155\/bio-2023-0079","article-title":"Evaluating the use of locked nucleic acid capture probes in hybrid LC\u2013MS\/MS analysis of siRNA analytes","volume":"15","author":"Agrawal","year":"2023","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib51","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4155\/bio-2023-0092","article-title":"Volumetric absorptive microsampling coupled with hybridization LC\u2013MS\/MS for quantitation of antisense oligonucleotides","volume":"15","author":"Chen","year":"2023","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116556","article-title":"Analyte and probe melting temperature guided method development strategy for hybridization LC\u2013MS\/MS quantification of siRNAs","volume":"253","author":"Song","year":"2025","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dmpk.2026.101545_bib53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/17576180.2025.2457894","article-title":"Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry","volume":"17","author":"Agrawal","year":"2025","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466575","article-title":"Hybridization liquid chromatography-mass spectrometry for quantitative bioanalysis of oligonucleotides: the upcoming paradigm shift","volume":"1766","author":"Yuan","year":"2026","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.dmpk.2026.101545_bib55","first-page":"791","article-title":"Bioanalysis of free antisense oligonucleotide payload from antibody-oligonucleotide conjugate by hybridization LC-MS\/MS","volume":"16","author":"Jiang","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib56","doi-asserted-by":"crossref","first-page":"16352","DOI":"10.1021\/acs.analchem.3c03621","article-title":"Sequencing of morpholino antisense oligonucleotides using electron capture dissociation mass spectrometry","volume":"95","author":"Karasawa","year":"2023","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmpk.2026.101545_bib57","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4155\/bio-2016-0289","article-title":"Quantitative determination of AVI-7100 (radavirsen), a phosphorodiamidate morpholino oligomer (PMOplus\u00ae), in human plasma using LC-MS\/MS","volume":"9","author":"Meng","year":"2017","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00216-019-02236-9","article-title":"Analytical and preparative separation of phosphorothioated oligonucleotides: columns and ion-pair reagents","volume":"412","author":"Enmark","year":"2020","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.dmpk.2026.101545_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0021-9673(02)00306-0","article-title":"Ion-pair reversed-phase high-performance liquid chromatography analysis of oligonucleotides: retention prediction","volume":"958","author":"Gilar","year":"2002","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.dmpk.2026.101545_bib60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpba.2012.09.007","article-title":"Evaluation of core-shell particle columns for ion-pair reversed-phase liquid chromatography analysis of oligonucleotides","volume":"72","author":"Biba","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dmpk.2026.101545_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113451","article-title":"Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC\u2013MS\/MS","volume":"188","author":"Franzoni","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dmpk.2026.101545_bib62","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpba.2017.12.027","article-title":"Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC\u2013MS\/MS","volume":"150","author":"Franzoni","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dmpk.2026.101545_bib63","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4155\/bio.12.117","article-title":"Development of a bioanalytical method for quantification of a 15-mer oligonucleotide at sub-ng\/ml concentrations using LC\u2013MS\/MS","volume":"4","author":"Hemsley","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462247","article-title":"Mitigation of analyte loss on metal surfaces in liquid chromatography","volume":"1650","author":"Gilar","year":"2021","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.dmpk.2026.101545_bib65","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4155\/bio-2021-0115","article-title":"Assessing the impact of nonspecific binding on oligonucleotide bioanalysis","volume":"13","author":"Nguyen","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463324","article-title":"The impact of low adsorption surfaces for the analysis of DNA and RNA oligonucleotides","volume":"1677","author":"Lardeux","year":"2022","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.dmpk.2026.101545_bib67","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4155\/bio-2023-0218","article-title":"Development, validation and application of an ion-pair reversed-phase liquid chromatography-tandem mass spectrometry method for the quantification of nusinersen","volume":"16","author":"Zhang","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmpk.2026.101545_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.70138","article-title":"Development and validation of an LC\u2013MS\/MS assay for quantitative analysis of nusinersen in human CSF and plasma","volume":"39","author":"Xu","year":"2025","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.dmpk.2026.101545_bib69","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/acsptsci.4c00698","article-title":"A bioanalytical liquid chromatography tandem mass spectrometry approach for the quantification of a novel antisense oligonucleotide designed for Parkinson's disease: a rat brain biodistribution study","volume":"8","author":"Palaiologou","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.dmpk.2026.101545_bib70","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s13361-017-1671-6","article-title":"Assessing the interplay between the physicochemical parameters of ion-pairing reagents and the analyte sequence on the electrospray desorption process for oligonucleotides","volume":"28","author":"Basiri","year":"2017","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.dmpk.2026.101545_bib71","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/rcm.7596","article-title":"Reduction of metal adducts in oligonucleotide mass spectra in ion-pair reversed-phase chromatography\/mass spectrometry analysis","volume":"30","author":"Birdsall","year":"2016","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.dmpk.2026.101545_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13361-012-0509-5","article-title":"The effect of organic modifiers on electrospray ionization charge-state distribution and desorption efficiency for oligonucleotides","volume":"24","author":"Chen","year":"2013","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.dmpk.2026.101545_bib73","doi-asserted-by":"crossref","first-page":"12155","DOI":"10.1021\/acs.analchem.5c00644","article-title":"Quantitative determination of click-reactive antisense oligonucleotide and its reactivity in rat brains by hybridization LC\u2013MS\/MS to support pretargeted PET imaging","volume":"97","author":"Jiang","year":"2025","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmpk.2026.101545_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461473","article-title":"Optimizing sample preparation workflow for bioanalysis of oligonucleotides through liquid chromatography tandem mass spectrometry","volume":"1629","author":"Liu","year":"2020","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.dmpk.2026.101545_bib75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.chroma.2005.12.004","article-title":"Stainless steel electrospray probe: a dead end for phosphorylated organic compounds?","volume":"1104","author":"Tuytten","year":"2006","journal-title":"J Chromatogr A"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436726000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436726000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:55:06Z","timestamp":1789466106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436726000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"alternative-id":["S1347436726000315"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2026.101545","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of LC\u2013MS-based bioanalytical methods for oligonucleotide therapeutics: points to consider","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2026.101545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101545"}}